Kessler, RC, Aguilar-Gaxiola, S, Alonso, J, Chatterji, S, Lee, S, Ormel, J, et al. The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys. Epidemiol Psichiatr Soc
2009; 18: 23–33.
Wittchen, HU, Kessler, RC, Beesdo, K, Krause, P, Hofler, M, Hoyer, J. Generalized anxiety and depression in primary care: prevalence, recognition, and management. J Clin Psychiatry
2002; 63 (suppl 8): 24–34.
Bodlund, O. [Anxiety and depression as a hidden problem in primary health care. Only one case in four identified]. Lakartidningen
1997; 94: 4612–4614, .
Lotfi, L, Flyckt, L, Krakau, I, Martensson, B, Nilsson, GH. Undetected depression in primary healthcare: occurrence, severity and co-morbidity in a two-stage procedure of opportunistic screening. Nord J Psychiatry
2010; 64: 421–7.
Alonso, J, Angermeyer, MC, Bernert, S, Bruffaerts, R, Brugha, TS, Bryson, H, et al. Use of mental health services in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl
2004; 420: 47–54.
Mayes, R, Horwitz, AV. DSM-III and the revolution in the classification of mental illness. J Hist Behav Sci
2005; 41: 249–67.
Horwitz, AV. Transforming normality into pathology: the DSM and the outcomes of stressful social arrangements. J Health Soc Behav
2007; 48: 211–22.
Busfield, J. Challenging claims that mental illness has been increasing and mental well-being declining. Soc Sci Med
2012; 75: 581–8.
Mojtabai, R, Olfson, M. Proportion of antidepressants prescribed without a psychiatric diagnosis is growing. Health Aff
2011; 30: 1434–42.
Dowrick, C, Frances, A. Medicalising unhappiness: new classification of depression risks more patients being put on drug treatment from which they will not benefit. BMJ
2013; 347: f7140.
Lejtzen, N, Sundquist, J, Sundquist, K, Li, X. Depression and anxiety in Swedish primary health care: prevalence, incidence, and risk factors. Eur Arch Psychiatry Clin Neurosci
2014; 264: 235–45.
Alonso, J, Angermeyer, MC, Bernert, S, Bruffaerts, R, Brugha, TS, Bryson, H, et al. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl
2004; 420: 21–7.
Marcus, SM, Young, EA, Kerber, KB, Kornstein, S, Farabaugh, AH, Mitchell, J, et al. Gender differences in depression: findings from the STAR*D study. J Affect Disord
2005; 87: 141–50.
Alexandrino-Silva, C, Wang, YP, Carmen Viana, M, Bulhoes, RS, Martins, SS, Andrade, LH. Gender differences in symptomatic profiles of depression: results from the Sao Paulo Megacity Mental Health Survey. J Affect Disord
2013; 147: 355–64.
Martin, LA, Neighbors, HW, Griffith, DM. The experience of symptoms of depression in men vs women: analysis of the National Comorbidity Survey Replication. JAMA Psychiatry
2013; 70: 1100–6.
Hildebrandt, MG, Stage, KB, Kragh-Soerensen, P. Gender differences in severity, symptomatology and distribution of melancholia in major depression. Psychopathology
2003; 36: 204–12.
Silverstein, B, Edwards, T, Gamma, A, Ajdacic-Gross, V, Rossler, W, Angst, J. The role played by depression associated with somatic symptomatology in accounting for the gender difference in the prevalence of depression. Soc Psychiatry Psychiatr Epidemiol
2013; 48: 257–63.
Klose, M, Jacobi, F. Can gender differences in the prevalence of mental disorders be explained by sociodemographic factors?
Arch Womens Ment Health
2004; 7: 133–48.
Hyde, JS, Mezulis, AH, Abramson, LY. The ABCs of depression: integrating affective, biological, and cognitive models to explain the emergence of the gender difference in depression. Psychol Rev
2008; 115: 291–313.
Gelenberg, AJ. A review of the current guidelines for depression treatment. J Clin Psychiatry
2010; 71: e15.
Abbing-Karahagopian, V, Huerta, C, Souverein, PC, de Abajo, , Leufkens, HG, Slattery, J, et al. Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications. Eur J Clin Pharmacol
2014; 70: 849–57.
Wettermark, B, Hammar, N, Fored, CM, Leimanis, A, Otterblad Olausson, P, Bergman, U, et al. The new Swedish Prescribed Drug Register – opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf
2007; 16: 726–35.
Ohayon, MM, Lader, MH. Use of psychotropic medication in the general opulation of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry
2002; 63: 817–25.
Noordam, R, Aarts, N, Verhamme, KM, Sturkenboom, MC, Stricker, BH, Visser, LE. Prescription and indication trends of antidepressant drugs in the Netherlands between 1996 and 2012: a dynamic population-based study. Eur J Clin Pharmacol
2015; 71: 369–75.
Boyd, A, Van de Velde, S, Pivette, M, ten Have, M, Florescu, S, O'Neill, S, et al. Gender differences in psychotropic use across Europe: Results from a large cross-sectional, population-based study. Eur Psychiatry
2015; 30: 778–88.
Henriksson, S, Asplund, R, Boethius, G, Hallstrom, T, Isacsson, G. Infrequent use of antidepressants in depressed individuals (an interview and prescription database study in a defined Swedish population 2001-2002). Eur Psychiatry
2006; 21: 355–60.
Demyttenaere, K, Bruffaerts, R, Posada-Villa, J, Gasquet, I, Kovess, V, Lepine, JP, et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA
2004; 291: 2581–90.
Bauer, M, Monz, BU, Montejo, AL, Quail, D, Dantchev, N, Demyttenaere, K, et al. Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study. Eur Psychiatry
2008; 23: 66–73.
MacGillivray, S, Arroll, B, Hatcher, S, Ogston, S, Reid, I, Sullivan, F, et al. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis. BMJ
2003; 326: 1014.
NOMESCO. Medicines Consumption in the Nordic Countries 2004-2008. Nordic Medico Statistical Committee, 2009.
Zigmond, AS, Snaith, RP. The hospital anxiety and depression scale. Acta Psychiatr Scand
1983; 67: 361–70.
Bjelland, I, Dahl, AA, Haug, TT, Neckelmann, D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res
2002; 52: 69–77.
Wettermark, B, Zoega, H, Furu, K, Korhonen, M, Hallas, J, Norgaard, M, et al. The Nordic prescription databases as a resource for pharmacoepidemiological research – a literature review. Pharmacoepidemiol Drug Saf
2013; 22: 691–9.
World Health Organization. Guidelines for ATC classification and DDD assignment.
WHO Collaborating Centre for Drug Statistics Methodology, 2005.
Hirshbein, L. Challenges to diagnosis and treatment of depression in men. MD Advis
2012; 5: 24–8.
Kovess-Masfety, V, Boyd, A, van de Velde, S, de Graaf, R, Vilagut, G, Haro, JM, et al. Are there gender differences in service use for mental disorders across countries in the European Union? Results from the EU-World Mental Health survey. J Epidemiol Community Health
2014; 68: 649–56.
Breeman, S, Cotton, S, Fielding, S, Jones, GT. Normative data for the Hospital Anxiety and Depression Scale. Qual Life Res
2015; 24: 391–8.
Crawford, JR, Henry, JD, Crombie, C, Taylor, EP. Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol
2001; 40: 429–34.
Thunander Sundbom, L, Bingefors, K. Women and men report different behaviours in, and reasons for medication nonadherence: a nationwide Swedish survey. Pharm Pract
2012; 10: 207–21.
Thunander Sundbom, L, Bingefors, K. The influence of symptoms of anxiety and depression on medication nonadherence and its causes: a population based survey of prescription drug users in Sweden. Patient Prefer Adherence
2013; 7: 805–11.
DiMatteo, MR, Lepper, HS, Croghan, TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med
2000; 160: 2101–7.
Bulloch, AG, Patten, SB. Nonadherence with psychotropic medications in the general population. Soc Psychiatry Psychiatr Epidemiol
2010; 45: 47–56.
Simoni-Wastila, L. Gender and psychotropic drug use. Med Care
1998; 36: 88–94.
Owens, GM. Gender differences in health care expenditures, resource utilization, and quality of care. J Manag Care Pharm
2008; 14 (suppl 3): 2–6.
Skoog, J, Midlov, P, Beckman, A, Sundquist, J, Halling, A. Drugs prescribed by general practitioners according to age, gender and socioeconomic status after adjustment for multimorbidity level. BMC Fam Pract
2014; 15: 183.
Moynihan, R, Doust, J, Henry, D. Preventing overdiagnosis: how to stop harming the healthy. BMJ
2012; 344: e3502.
Fournier, JC, DeRubeis, RJ, Hollon, SD, Dimidjian, S, Amsterdam, JD, Shelton, RC, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA
2010; 303: 47–53.
Mercier, A, Auger-Aubin, I, Lebeau, JP, Schuers, M, Boulet, P, Hermil, JL, et al. Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: an analysis of guidelines and systematic reviews. BMC Fam Pract
2013; 14: 55.
Keers, R, Aitchison, KJ. Gender differences in antidepressant drug response. Int Rev Psychiatry
2010; 22: 485–500.
Young, AH. Gender differences in treatment response to antidepressants. Br J Psychiatry
2001; 179: 561.
Cochran, SV, Rabinovitz, FE. Gender-sensitive recommendations for assessment and treatment of depression in men. Prof Psych Res Pract
2003; 34: 132–40.
Quitkin, FM, Stewart, JW, McGrath, PJ, Taylor, BP, Tisminetzky, MS, Petkova, E, et al. Are there differences between women's and men's antidepressant responses?
Am J Psychiatry
2002; 159: 1848–54.
Henriksson, S, Boethius, G, Hakansson, J, Isacsson, G. Indications for and outcome of antidepressant medication in a general population: a prescription database and medical record study, in Jamtland county, Sweden, 1995. Acta Psychiatr Scand
2003; 108: 427–31.